SDRC Pilot and Feasibility Awards
2022 Pilot and Feasibility Awards
Based on our recent Pilot and Feasibility request for applications, we received 14 project proposals. With the support of MCHRI to complement the NIH P30 funding, the Stanford Diabetes Research Center (SDRC) proudly announces the following 6 awardees.
SDRC is committed to providing support for the most innovative and unique research proposals related to diabetes in all disciplines. Our goal is to support, enhance and foster new ideas that will improve how we understand, diagnose, treat and care for diabetes and its complications. The P&F program is a DRC hallmark designed to meet this goal.
Thank you to all applicants for their submissions, and congratulations again to this year's awardees.
Eric Appel PhD | Assistant Professor, Materials Science and Engineering
Collaborator: Holden Maecker, PhD
“Development of a tolerogenic vaccine for the prevention of type 1 diabetes”
Martha Cyert, PhD | Professor, Biology
Collaborators: Sohail Husain, MD
“Mapping calcineurin signaling pathways that cause pancreatitis”
Joshua Knowles, MD PhD | Assistant Professor, Medicine (Cardiovascular Medicine)
Collaborators: Katrin Svensson, PhD
“Hepatic G protein-coupled receptor 151 as a target for type 2 diabetes treatment”
Sooyeon Lee, PhD | Instructor, Medicine (Endocrinology, Gerontology & Metabolism)
“The pathophysiological role of Succinate Dehydrogenase deficiency in β-cell aging and diabetes”
Michele Patel, PhD | Instructor, Department of Medicine (SPRC)
Collaborators: Lisa Goldman Rosas, PhD MPH
“Goal-setting in a standalone, digital weight loss intervention: a pilot factorial trial”
Eric Stice, PhD | Professor, Psychiatry and Behavioral Sciences
“Evaluating a Brief Type 2 Diabetes Prevention Program with Greater Scalability”
